Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherri L Christian

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Oncotargets and Therapy|November 25, 2022
CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current InsightsSherri L Christian
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2022
Overview of the Maintenance of Authentic Cancer Cell LinesSherri L Christian
Frontiers in Immunology|March 13, 2024
Editorial: CD24 in the regulation of cellular development and diseaseSherri L Christian, Geraldine Cambridge
Frontiers in Pharmacology|July 18, 2018
Trace Amine-Associated Receptors as Novel Therapeutic Targets for Immunomodulatory DisordersSherri L Christian, Mark D Berry
Frontiers in Cell and Developmental Biology|January 14, 2017
CD24: A Rheostat That Modulates Cell Surface Receptor Signaling of Diverse ReceptorsD Craig Ayre, Sherri L Christian
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2022
Characterizing Extracellular Vesicles Using Nanoparticle-Tracking AnalysisModeline N Longjohn, Sherri L Christian
Advances in Experimental Medicine and Biology|February 11, 2020
Adipocytes in the Tumour MicroenvironmentNikitha K Pallegar, Sherri L Christian
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2022
Culturing Suspension Cancer Cell LinesModeline N Longjohn, Hong-Dien Phan, Sherri L Christian
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3Sherri L Christian, Peter V Sims, Michael R Gold
Frontiers in Cell and Developmental Biology|August 25, 2015
Repression of CD24 surface protein expression by oncogenic Ras is relieved by inhibition of Raf but not MEK or PI3KNikitha K Pallegar, D Craig Ayre, Sherri L Christian
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Oncotargets and Therapy|November 25, 2022
CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current InsightsSherri L Christian
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2022
Overview of the Maintenance of Authentic Cancer Cell LinesSherri L Christian
Frontiers in Immunology|March 13, 2024
Editorial: CD24 in the regulation of cellular development and diseaseSherri L Christian, Geraldine Cambridge
Frontiers in Pharmacology|July 18, 2018
Trace Amine-Associated Receptors as Novel Therapeutic Targets for Immunomodulatory DisordersSherri L Christian, Mark D Berry
Frontiers in Cell and Developmental Biology|January 14, 2017
CD24: A Rheostat That Modulates Cell Surface Receptor Signaling of Diverse ReceptorsD Craig Ayre, Sherri L Christian
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2022
Characterizing Extracellular Vesicles Using Nanoparticle-Tracking AnalysisModeline N Longjohn, Sherri L Christian
Advances in Experimental Medicine and Biology|February 11, 2020
Adipocytes in the Tumour MicroenvironmentNikitha K Pallegar, Sherri L Christian
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2022
Culturing Suspension Cancer Cell LinesModeline N Longjohn, Hong-Dien Phan, Sherri L Christian
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3Sherri L Christian, Peter V Sims, Michael R Gold
Frontiers in Cell and Developmental Biology|August 25, 2015
Repression of CD24 surface protein expression by oncogenic Ras is relieved by inhibition of Raf but not MEK or PI3KNikitha K Pallegar, D Craig Ayre, Sherri L Christian
Pageof 6